Fiche personne
Coordonnées
UMR 7365 CNRS-UL IMoPA
Biopôle de l’Université de Lorraine
Campus Biologie Santé
9 Avenue de la Forêt de Haye
CS 50184
54505 VANDOEUVRE-LES-NANCY
03 72 74 66 22
Territoire
Lorraine
Statut
Hospitalo-Universitaire
Équipes/plateformes
Publications
The adiponectin agonist AdipoRon accelerates osteoporosis development in two different models and modulates adipocyte differentiation.
Halper J, Nicolas S, Gilardi F, Winkler C, Materozzi M, Schiffrin M, Jouzeau JY, Blin-Wakkach C, Desvergne B, Chabry J, Pisani DF, Moulin D
Bone. 2025 09 3;:117628
Advanced Combination Therapy in Inflammatory Bowel Disease.
Morizot C, Sequier L, Jouzeau JY, Moulin D, Netter P, Caron B, Honap S, Lœuille D, Peyrin-Biroulet L
Joint Bone Spine. 2025 05 23;:105922
Detection of ketamine in the oral fluid of drivers in northeastern France during the years 2020-2023.
Aouichi LL, Pape E, Jouzeau JY, Gibaja V, Aubin-Beale E, Kolodziej A, Feliu C, Marchand E, Gambier N, Scala-Bertola J
Fundam Clin Pharmacol. 2025 04;39(2):e13060
Emerging Detection of Hexahydrocannabinol in Driver Saliva: Preliminary Data.
Derne AS, Jouzeau JY, Pape E, Kolodziej A, Gibaja V, Marchand E, Gambier N, Scala-Bertola J
Eur Addict Res. 2024 11 15;:1-6
Outside-in hair contamination by blood containing opiates and opioids.
Czech A, Scala-Bertola J, Pape E, Kolodziej A, Tscheiller N, Jouzeau JY, Marchand E, Gambier N
Forensic Sci Int. 2024 11 15;365:112298
Evaluation of amphetamines diffusion in hair after contact with amphetamines-containing blood.
Tscheiller N, Marchand E, Pape E, Czech A, Wakim JN, Kolodziej A, Jouzeau JY, Scala-Bertola J, Gambier N
Forensic Sci Int. 2024 02 8;356:111966
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis.
Moulin D, Millard M, Taïeb M, Michaudel C, Aucouturier A, Lefèvre A, Bermúdez-Humarán LG, Langella P, Sereme Y, Wanherdrick K, Gautam P, Mariette X, Dieudé P, Gottenberg JE, Jouzeau JY, Skurnik D, Emond P, Mulleman D, Sellam J, Sokol H
Ann Rheum Dis. 2023 11 24;:
In vitro stability study of 10 beta-lactam antibiotics in human plasma samples.
Brenkman M, Cartau T, Pape E, Kolodziej A, Charmillon A, Novy E, Jouzeau JY, Gambier N, Scala-Bertola J
Fundam Clin Pharmacol. 2023 11 20;:
Immunological detection of hexahydrocannabinol (HHC) in oral fluid.
Derne AS, Pape E, Jouzeau JY, Kolodziej A, Gambier N, Scala-Bertola J
Drug Test Anal. 2023 11 2;:
Emerging role of IκBζ in inflammation: Emphasis on psoriasis.
Gautam P, Maenner S, Cailotto F, Reboul P, Labialle S, Jouzeau JY, Bourgaud F, Moulin D
Clin Transl Med. 2022 10;12(10):e1032
Identification of circulating biomarkers of Crohn's disease and spondyloarthritis using FTIR spectroscopy.
Prada P, Brunel B, Moulin D, Rouillon L, Netter P, Loeuille D, Slimano F, Bouche O, Peyrin-Biroulet L, Jouzeau JY, Piot O
J Biophotonics. 2022 09 16;:e202200200
Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models.
Vieujean S, Caron B, Haghnejad V, Jouzeau JY, Netter P, Heba AC, Ndiaye NC, Moulin D, Barreto G, Danese S, Peyrin-Biroulet L
Int J Mol Sci. 2022 07 9;23(14):
Online SPE UPLC-MS/MS method for the simultaneous determination of 33 psychoactive drugs from swab-collected human oral fluid samples.
Mercier B, Scala-Bertola J, Pape E, Kolodziej A, Gibaja V, Bisch M, Jouzeau JY, Gambier N
Anal Bioanal Chem. 2022 Apr 22;:
Anti-Inflammatory Activity of Bryophytes Extracts in LPS-Stimulated RAW264.7 Murine Macrophages.
Marques RV, Sestito SE, Bourgaud F, Miguel S, Cailotto F, Reboul P, Jouzeau JY, Rahuel-Clermont S, Boschi-Muller S, Simonsen HT, Moulin D
Molecules. 2022 Mar 17;27(6):
Gastroenterological safety of IL-17 inhibitors: a systematic literature review.
Caron B, Jouzeau JY, Miossec P, Petitpain N, Gillet P, Netter P, Peyrin-Biroulet L
Expert Opin Drug Saf. 2021 Jul 26;:
Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs.
Ferhat M, Hablot J, Taieb M, Salem F, Netter P, Peyrin-Biroulet L, Jouzeau JY, Moulin D
Clin Transl Med. 2021 Jun;11(6):e455
IL-17 inhibitors and inflammatory bowel diseases: a post-marketing study in Vigibase®.
Petitpain N, D'Amico F, Yelehe-Okouma M, Jouzeau JY, Netter P, Peyrin-Biroulet L, Gillet P
Clin Pharmacol Ther. 2021 Jan 7;:
Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic Mice.
Madel MB, Fu H, Pierroz DD, Schiffrin M, Winkler C, Wilson A, Pochon C, Toffoli B, Taïeb M, Jouzeau JY, Gilardi F, Ferrari S, Bonnet N, Blin-Wakkach C, Desvergne B, Moulin D
Front Cell Dev Biol. 2021 ;9:627153
Multiplex detection of 14 fentanyl analogues and U-47700 in biological samples: Application to a panel of French hospitalized patients.
Jung J, Kolodziej A, Pape E, Bisch M, Javot L, Gibaja V, Jouzeau JY, Scala-Bertola J, Gambier N
. 2020 Sep 6;317:110437
Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis.
Hablot J, Ferhat M, Lavelle A, Salem F, Taieb M, Medvedovic J, Kindt N, Reboul P, Cailotto F, Jouzeau JY, Eberl G, Sokol H, Moulin D
. 2020 Sep;10(5):e163
Paradoxical gastrointestinal effects of interleukin-17 blockers.
Fauny M, Moulin D, D'Amico F, Netter P, Petitpain N, Arnone D, Jouzeau JY, Loeuille D, Peyrin-Biroulet L
Ann. Rheum. Dis.. 2020 Jul 21;:
Identification of TGFβ signatures in six murine models mimicking different osteoarthritis clinical phenotypes.
Maumus M, Noel D, Ea HK, Moulin D, Ruiz M, Hay E, Houard X, Cleret D, Cohen-Solal M, Jacques C, Jouzeau JY, Lafage-Proust MH, Reboul P, Sellam J, Vinatier C, Rannou F, Jorgensen C, Guicheux J, Berenbaum F
Osteoarthr. Cartil.. 2020 Jul 10;:
Mast cells in spondyloarthritis, more than simple inflammatory bystanders?
Polivka L, Frenzel L, Jouzeau JY, Hermine O, Moulin D
Ther Adv Musculoskelet Dis. 2020 ;12:1759720X20971907
Secreted Frizzled-related proteins (sFRPs) in osteo-articular diseases: much more than simple antagonists of Wnt signaling?
Claudel M, Jouzeau JY, Cailotto F
FEBS J.. 2019 Nov 2;:
Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
Salem F, Kindt N, Marchesi JR, Netter P, Lopez A, Kokten T, Danese S, Jouzeau JY, Peyrin-Biroulet L, Moulin D
United European Gastroenterol J. 2019 Oct;7(8):1008-1032
CRD generated by pCARGHO: A new efficient lectin-based affinity tag method for safe, simple and low-cost protein purification.
Kriznik A, Yéléhé-Okouma M, Lec JC, Groshenry G, Le Cordier H, Charron C, Quinternet M, Mazon H, Talfournier F, Boschi-Muller S, Jouzeau JY, Reboul P
Biotechnol J. 2018 Oct 8;:e1800214
Zinc-Alpha-2-Glycoprotein in Inflammatory Bowel Disease.
Rolli V, Macquin C, Kokten T, Hablot J, Ndiaye NC, Netter P, Bahram S, Jouzeau JY, Peyrin-Biroulet L, Georgel P, Moulin D
Inflamm. Bowel Dis.. 2018 Apr 23;24(5):e10
Lack of Adipocytes Alters Hematopoiesis in Lipodystrophic Mice.
Wilson A, Fu H, Schiffrin M, Winkler C, Koufany M, Jouzeau JY, Bonnet N, Gilardi F, Renevey F, Luther SA, Moulin D, Desvergne B
Front Immunol. 2018 ;9:2573
Management of patients with inflammatory bowel disease and spondyloarthritis.
Pouillon L, Bossuyt P, Vanderstukken J, Moulin D, Netter P, Danese S, Jouzeau JY, Loeuille D, Peyrin-Biroulet L
Expert Rev Clin Pharmacol. 2017 Sep;:
TREM-1 inhibition restores impaired autophagy activity and reduces colitis in mice.
Kökten T, Gibot S, Lepage P, D'Alessio S, Hablot J, Ndiaye NC, Busby-Venner H, Monot C, Garnier B, Moulin D, Jouzeau JY, Hansmannel F, Danese S, Guéant JL, Muller S, Peyrin-Biroulet L
J Crohns Colitis. 2017 Sep;:
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.
Allen PB, Olivera P, Emery P, Moulin D, Jouzeau JY, Netter P, Danese S, Feagan B, Sandborn WJ, Peyrin-Biroulet L
Aliment. Pharmacol. Ther.. 2017 Apr;45(8):1058-1072
Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice.
Hablot J, Peyrin-Biroulet L, Kokten T, El Omar R, Netter P, Bastien C, Jouzeau JY, Sokol H, Moulin D
PLoS ONE. 2017 ;12(9):e0184624
Galectin-3: A key player in arthritis.
Hu Y, Yéléhé-Okouma M, Ea HK, Jouzeau JY, Reboul P
Joint Bone Spine. 2017 Jan;84(1):15-20
MicroRNA-29b Contributes to Collagens Imbalance in Human Osteoarthritic and Dedifferentiated Articular Chondrocytes.
Moulin D, Salone V, Koufany M, Clément T, Behm-Ansmant I, Branlant C, Charpentier B, Jouzeau JY
Biomed Res Int. 2017 ;2017:9792512
Fibroblast Growth Factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a Klotho-independent manner.
Bianchi A, Guibert M, Cailotto F, Gasser A, Presle N, Mainard D, Netter P, Kempf H, Jouzeau JY, Reboul P
Osteoarthr. Cartil.. 2016 Nov;24(11):1961-1969
Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review.
Latar I, Koufany M, Hablot J, Loeuille D, Netter P, Jouzeau JY, Chary-Valckenaere I, Moulin D
Clin. Rheumatol.. 2016 Oct;35(10):2619-23
Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations.
Pape E, Scala-Bertola J, Petitpain N, Jouzeau JY, Charrois-Sciaudeau S, Kemmel V, Barraud H, Gambier N
Transplantation. 2015 Sep;99(9):e163-4
Elevated Hepatocyte Growth Factor Levels in Osteoarthritis Osteoblasts Contribute to their Altered Response to Bone Morphogenetic Protein-2 and Reduced Mineralization Capacity.
Abed E, Bouvard B, Martineau X, Jouzeau JY, Reboul P, Lajeunesse D
Bone. 2015 Feb 6. pii: S8756-3282(15)00038-1
Identification of two populations of osteoarthritic osteoblasts according to the 1,25[OH](2) vitamin D(3) potency to stimulate osteocalcin.
Hu Y, Liu Y, Lajeunesse D, Mainard D, Jouzeau JY, Reboul P
Biomed Mater Eng. 2015;25(1 Suppl):103-10
Oxidative stress-induced expression of HSP70 contributes to the inhibitory effect of 15d-PGJ2 on inducible prostaglandin pathway in chondrocytes.
Bianchi A, Moulin D, Hupont S, Koufany M, Netter P, Reboul P, Jouzeau JY
Free Radic Biol Med. 2014 Nov;76:114-26
Chemical and pharmacological basics of NSAIDs.
Trechot P, Jouzeau JY
Rev Fr Allergol. 2014 Apr;54(3):212-7.
Association between adiponectin and cartilage degradation in human osteoarthritis.
Francin PJ, Abot A, Guillaume C, Moulin D, Bianchi A, Gegout-Pottie P, Jouzeau JY, Mainard D, Presle N
Osteoarthritis Cartilage. 2014 Mar;22(3):519-26
Death of an alcohol-dependent patient following intentional drug intoxication: implication of baclofen?
Pape E, Roman E, Scala-Bertola J, Thivilier C, Javot L, Saint-Marcoux F, Jouzeau JY, Gambier N
Eur Addict Res. 2014;20(6):300-4
Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
Koufany M, Jouzeau JY, Moulin D
Biomed Mater Eng. 2014;24(1 Suppl):81-8
Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts.
Bouvard B, Abed E, Yelehe-Okouma M, Bianchi A, Mainard D, Netter P, Jouzeau JY, Lajeunesse D, Reboul P
Arthritis Res Ther. 2014 Oct 14;16(5):459
Identification of new microRNAs targeting genes regulating the Pi/PPi balance in chondrocytes.
Clement T, Salone V, Charpentier B, Jouzeau JY, Bianchi A
Biomed Mater Eng. 2014;24(1 Suppl):3-16
Phosphate-induced mineralization of tracheal smooth muscle and cartilage cells.
Tabcheh L, Bianchi A, Clement A, Jouzeau JY, Kempf H
Biomed Mater Eng. 2014;24(1 Suppl):37-45
The peroxisome proliferator-activated receptor gamma agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.
Koufany M, Chappard D, Netter P, Bastien C, Weryha G, Jouzeau JY, Moulin D
Arthritis Rheum. 2013 Dec;65(12):3084-95
Role of nicotinic acid and nicotinamide in nicorandil-induced ulcerations: from hypothesis to demonstration.
Trechot P, Jouzeau JY, Brouillard C, Scala-Bertola J, Petitpain N, Cuny JF, Gauchotte G, Schmutz JL, Barbaud A
Int Wound J. 2013 Sep 13
Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?
Paquet J, Goebel JC, Delaunay C, Pinzano A, Grossin L, Cournil-Henrionnet C, Gillet P, Netter P, Jouzeau JY, Moulin D
Arthritis Res Ther. 2012 Mar 13;14(2):R60
Calcium input potentiates the transforming growth factor (TGF)-beta1-dependent signaling to promote the export of inorganic pyrophosphate by articular chondrocyte.
Cailotto F, Reboul P, Sebillaud S, Netter P, Jouzeau JY, Bianchi A
J Biol Chem. 2011 Jun 3;286(22):19215-28
The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte.
Cailotto F, Sebillaud S, Netter P, Jouzeau JY, Bianchi A
J Biol Chem. 2010 Apr 2;285(14):10572-82
Inorganic phosphate (Pi) modulates the expression of key regulatory proteins of the inorganic pyrophosphate (PPi) metabolism in TGF-beta1-stimulated chondrocytes.
Hamade T, Bianchi A, Sebillaud S, Netter P, Jouzeau JY, Cailotto F
Biomed Mater Eng. 2010 Jan 1;20(3):209-15.
All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation.
Kirchmeyer M, Koufany M, Sebillaud S, Netter P, Jouzeau JY, Bianchi A
Arthritis Res Ther. 2008;10(6):R141
Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau JY
Arthritis Res Ther. 2008;10(1):R6
[Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases - the pro and con of agonists]
Jouzeau JY, Moulin D, Koufany M, Sebillaud S, Bianchi A, Netter P
J Soc Biol. 2008;202(4):289-312
Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes.
Cailotto F, Bianchi A, Sebillaud S, Venkatesan N, Moulin D, Jouzeau JY, Netter P
Arthritis Res Ther. 2007;9(6):R122.
Effect of peroxisome proliferator activated receptor (PPAR)gamma agonists on prostaglandins cascade in joint cells.
Moulin D, Poleni PE, Kirchmeyer M, Sebillaud S, Koufany M, Netter P, Terlain B, Bianchi A, Jouzeau JY
Biorheology. 2006;43(3-4):561-75.
Uncoupling of oxidative phosphorylation and Smac/DIABLO release are not sufficient to account for induction of apoptosis by sulindac sulfide in human colorectal cancer cells.
Daouphars M, Koufany M, Benani A, Marchal S, Merlin JL, Netter P, Jouzeau JY
Int J Oncol. 2005 Apr;26(4):1069-77.
Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B
Arthritis Rheum. 2005 Mar;52(3):759-69.
Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostagl
Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY
Arthritis Res Ther. 2005;7(6):R1325-37
